TheProfitWatch

ANVS - Annovis Bio, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.88 -0.2 (-5.15%) --- 0.0 (0.0%) -0.05 (-1.47%) 0.02 (0.52%) -0.23 (-5.88%) -0.02 (-0.5%) -0.07 (-1.76%)

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.32
Diluted EPS:
-0.32
Basic P/E:
-11.5
Diluted P/E:
-11.5
RSI(14) 1m:
46.74
VWAP:
3.7
RVol:

Events

Period Kind Movement Occurred At

Related News